Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Crump

Showing results (211-220 of 230) with videos related to

Pageof 23
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2014
The role of body mass index in survival outcome for lymphoma patients: US intergroup experienceF Hong, T M Habermann, L I Gordon, et al.
Schizophrenia Research|February 23, 2019
Impact of "psychosis risk" identification: Examining predictors of how youth view themselvesLawrence H Yang, Kristen A Woodberry, Bruce G Link, et al.
Early Intervention in Psychiatry|June 2, 2020
Naturalistic conceptions of genetic optimism and precision psychiatry among those at clinical high-risk for psychosisDrew Blasco, Saige William Stortz, Margaux Marie-Rose Grivel, et al.
Plos Pathogens|August 30, 2024
Rab27a GTPase and its effector Myosin Va are host factors required for efficient Oropouche virus cell egressJuan O Concha, Kristel Gutierrez, Natalia Barbosa, et al.
International Journal of Hygiene and Environmental Health|November 2, 2020
Low-threshold SARS-CoV-2 testing facility for hospital staff: Prevention of COVID-19 outbreaks?T Menting, K Krause, F Benz-Tettey, et al.
Psychological Medicine|March 3, 2017
Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohortG Brucato, M D Masucci, L Y Arndt, et al.
Psychological Medicine|June 29, 2018
A predictive model for conversion to psychosis in clinical high-risk patientsAdam J Ciarleglio, Gary Brucato, Michael D Masucci, et al.
Cell Reports|April 23, 2024
HSV-1 employs UL56 to antagonize expression and function of cGAMP channelsHenry T W Blest, Alexander Redmond, Jed Avissar, et al.
Plos Pathogens|August 17, 2013
A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replicationSamantha J Griffiths, Manfred Koegl, Chris Boutell, et al.
Plos Pathogens|January 6, 2022
Correction: pUL21 is a viral phosphatase adaptor that promotes herpes simplex virus replication and spreadTomasz H Benedyk, Julia Muenzner, Viv Connor, et al.
Pageof 23

Showing results (211-220 of 230) with videos related to

Sort By:
Pageof 23
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2014
The role of body mass index in survival outcome for lymphoma patients: US intergroup experienceF Hong, T M Habermann, L I Gordon, et al.
Schizophrenia Research|February 23, 2019
Impact of "psychosis risk" identification: Examining predictors of how youth view themselvesLawrence H Yang, Kristen A Woodberry, Bruce G Link, et al.
Early Intervention in Psychiatry|June 2, 2020
Naturalistic conceptions of genetic optimism and precision psychiatry among those at clinical high-risk for psychosisDrew Blasco, Saige William Stortz, Margaux Marie-Rose Grivel, et al.
Plos Pathogens|August 30, 2024
Rab27a GTPase and its effector Myosin Va are host factors required for efficient Oropouche virus cell egressJuan O Concha, Kristel Gutierrez, Natalia Barbosa, et al.
International Journal of Hygiene and Environmental Health|November 2, 2020
Low-threshold SARS-CoV-2 testing facility for hospital staff: Prevention of COVID-19 outbreaks?T Menting, K Krause, F Benz-Tettey, et al.
Psychological Medicine|March 3, 2017
Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohortG Brucato, M D Masucci, L Y Arndt, et al.
Psychological Medicine|June 29, 2018
A predictive model for conversion to psychosis in clinical high-risk patientsAdam J Ciarleglio, Gary Brucato, Michael D Masucci, et al.
Cell Reports|April 23, 2024
HSV-1 employs UL56 to antagonize expression and function of cGAMP channelsHenry T W Blest, Alexander Redmond, Jed Avissar, et al.
Plos Pathogens|August 17, 2013
A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replicationSamantha J Griffiths, Manfred Koegl, Chris Boutell, et al.
Plos Pathogens|January 6, 2022
Correction: pUL21 is a viral phosphatase adaptor that promotes herpes simplex virus replication and spreadTomasz H Benedyk, Julia Muenzner, Viv Connor, et al.
Pageof 23